RETN and Insulin resistance: Indeed, although a specific resistin receptor has not yet been identified, TLR4 has been recognized as a binding site for resistin, where it activates a TLR4-mediated signaling pathway involved in resistin-induced inflammation and insulin resistance (Benomar et al, 2013).